Why over-reliance on rare genetic mutation models is misleading sporadic CNS drug discovery
10 Sept 2026
Preclinical Models
- What are the current unmet needs for disease models?
- What is the demand from drug discovery teams for in vitro models?
- What are the current trends in building and adopting in vitro or in vivo disease models?
- What is required to validate in vitro models?
Industry Expert
